Aytu BioPharma (NASDAQ:AYTU) Announces Quarterly Earnings Results

Aytu BioPharma (NASDAQ:AYTU) issued its quarterly earnings data on Wednesday. The company reported ($0.28) EPS for the quarter, Zacks reports. Aytu BioPharma had a negative return on equity of 21.89% and a negative net margin of 8.28%.

Aytu BioPharma Stock Down 0.4 %

AYTU traded down $0.01 on Friday, hitting $1.38. The company had a trading volume of 12,495 shares, compared to its average volume of 24,543. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.99 and a quick ratio of 0.80. Aytu BioPharma has a 52-week low of $1.30 and a 52-week high of $3.45. The stock has a fifty day simple moving average of $1.61 and a 200-day simple moving average of $2.00. The firm has a market capitalization of $8.46 million, a P/E ratio of -1.12 and a beta of -1.45.

About Aytu BioPharma

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.